# Cannabis &#038; Cannabinoid Research &#8211; All Issues &#8211; Sage Journals

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-cannabinoid-research-journal-sage/
> **Published:** 2026-03-31T12:08:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:34:09-04:00
> **Clinical Summary:** Explore the Cannabis Cannabinoid Research Journal by Sage, a trusted source for peer-reviewed cannabis medicine and cannabinoid research studies.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
ResearchEvidence-Based MedicineClinical PracticeAcademic PublishingCannabis Science

Why This Matters

Access to peer-reviewed [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) through established academic publishers like Sage represents a maturation of the field that directly benefits clinicians seeking evidence-based guidance. Quality research publication pathways are essential for translating laboratory findings into clinical practice recommendations.

Clinical Summary
Cannabis & [Cannabinoid Research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) journal, published by Sage, provides a dedicated venue for peer-reviewed research in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and science. The journal covers preclinical studies, clinical trials, pharmacology, and therapeutic applications across the spectrum of cannabis and [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/). This represents part of the growing academic infrastructure supporting evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) as the field transitions from anecdotal reporting to rigorous scientific investigation.

Dr. Caplan’s Take

“Having established publishers like Sage host dedicated cannabis journals signals that we’re moving past the ‘wild west’ phase of [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) into legitimate academic medicine. This gives clinicians a trusted source for peer-reviewed findings rather than relying on conference abstracts or industry-funded studies.”

Clinical Perspective
🧠 Clinicians should prioritize peer-reviewed sources like this when staying current with cannabis research, as the editorial oversight helps filter signal from noise. When evaluating any cannabis study, look for proper controls, adequate sample sizes, and transparent funding sources regardless of the publication venue.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20%26%20Cannabinoid%20Research%20-%20All%20Issues%20-%20Sage%20Journals%20%40drcaplan&url=https%3A//journals.sagepub.com/loi/ccb%3Fcf-mal-redirected%3Dtrue)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//journals.sagepub.com/loi/ccb%3Fcf-mal-redirected%3Dtrue)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20%26%20Cannabinoid%20Research%20-%20All%20Issues%20-%20Sage%20Journals%20--%20via%20%40drcaplan.bsky.social%20https%3A//journals.sagepub.com/loi/ccb%3Fcf-mal-redirected%3Dtrue)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://journals.sagepub.com/loi/ccb?cf-mal-redirected=true](https://journals.sagepub.com/loi/ccb?cf-mal-redirected=true)

Table of Contents

- [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system)
- [What type of medical content does this relate to?](#What_type_of_medical_content_does_this_relate_to)
- [What research areas are covered in this publication?](#What_research_areas_are_covered_in_this_publication)
- [Who is the target audience for this information?](#Who_is_the_target_audience_for_this_information)
- [How current is this information?](#How_current_is_this_information)
- [Related](#Related)

## FAQ

#### What is the CED Clinical Relevance rating system?

The CED Clinical Relevance system appears to be a classification method used by CED Clinic to categorize [medical research](https://cedclinic.com/cb2-receptor-agonist-parkinsons/) and developments. Rating #70 indicates “Notable Clinical Interest” for emerging findings or policy developments that warrant close monitoring by healthcare professionals.

#### What type of medical content does this relate to?

This content is specifically related to cannabis medicine and research. It falls under the CED Clinic’s cannabis news section, focusing on evidence-based medical applications and clinical practice developments in this field.

#### What research areas are covered in this publication?

The content covers multiple research domains including evidence-based medicine, clinical practice applications, and academic publishing. These areas suggest a comprehensive approach to cannabis-related [medical research](https://cedclinic.com/cb2-receptor-agonist-parkinsons/) and its practical implementation in healthcare settings.

#### Who is the target audience for this information?

The target audience appears to be healthcare professionals, researchers, and clinicians interested in cannabis medicine. The clinical relevance rating and evidence-based focus indicate it’s designed for medical practitioners seeking current developments in this specialized field.

#### How current is this information?

This information is marked as “New” indicating recent publication or updates. The classification as “emerging findings” suggests this represents the latest developments in [cannabis medicine research](https://cedclinic.com/cannabinoids-neuromuscular-communication-benefits/) and clinical applications.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cannabis & Cannabinoid Research – All Issues – Sage Journals”, “url”: “https://journals.sagepub.com/loi/ccb?cf-mal-redirected=true”, “datePublished”: “2026-03-31T11:28:12Z”, “about”: “cannabis cannabinoid research all issues sage”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Call for Abstracts | National Cannabis Research Conference | Duncan Mackie, Ph.D.](https://cedclinic.com/national-cannabis-research-conference-call-for-abstracts/)

Learn about upcoming opportunities to contribute to national cannabis research and engage with leading experts in the field.

[Submit Your Abstract](https://cedclinic.com/national-cannabis-research-conference-call-for-abstracts/)

Who is putting in the work for cannabis research? – YouTube

Discover the key researchers and institutions advancing cannabis science through dedicated studies and clinical trials.

Watch Now

The Science Behind Cannabis and Its Therapeutic Benefits – NUG Magazine

Explore detailed insights into the therapeutic potential of cannabis backed by scientific research and clinical evidence.

Read More

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
